Quick Menu

Upcoming Journals

International Journal of Biochemistry Research & Review

International Journal of Biochemistry Research & Review, ISSN: 2231-086X,Vol.: 20, Issue.: 4

Short Communication

Evaluation of High Levels of Triglycerides in Non-alcoholic Fatty Liver Disease


D. Santha Rao1*, V. Praveena1 and Bhukya Veeranna1

1ESIC Medical College, Sanathnagar, Hyderabad, India.


Article Information
(1) Enrico Sanjust, Associate Professor, Department of Internal Medical Sciences, University of Cagliari, Italy.
(1) Dhastagir Sheriff, Benghazi University, Libya.
(2) Elvira Bormusov, Technion Institute of Technology, Israel.
Complete Peer review History: http://www.sciencedomain.org/review-history/23151




Non-alcoholic fatty liver disease (NAFLD) is starting as accumulation of fat in the hepatocytes (steatosis) which is a sub-clinical condition in those who are not consuming alcohol. Non-alcoholic steatohepatitis (NASH) is a condition of steatosis, associated with inflammation of liver cell.  This is a clinical form of NAFLD, which is regarded as a major cause of cirrhosis of the liver [1]. This distinction between simple steatosis and NASH is important because the natural history of these categories differs substantially. Patients with simple steatosis usually have a benign prognosis from the point of view of liver disease [2-5]. In contrast, up to 20% of patients with NASH may ultimately develop advanced liver disease [2,4-6]. The prognosis of NASH-related cirrhosis is poor: It results in liver failure or liver-related death in approximately one third of cases [7,8]. Hepatocellular cancer is also a recently recognized complication of NASH-related cirrhosis [7,9].


Keywords :

Non- alcoholic fatty liver disease(NAFLD); Non alcoholic steatohepatitis(NASH); cirrhosis; liver failure; Hepatocellular cancer; advanced liver disease.


Full Article - PDF    Page 1-5    Article Metrics


DOI : 10.9734/IJBCRR/2017/33499

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...


  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.